Semaglutide and bone health take center stage in a clear, reader-friendly look at a large real-world study, outlining its methods and implications.
Key Takeaways
- In a large real world study, semaglutide use was associated with fewer bone fractures
- This reduction occurred despite greater weight loss among semaglutide treated individuals
- These findings suggest semaglutide associated weight loss does not necessarily increase fracture risk